GSK plc (LON:GSK)
1,786.00
-3.50 (-0.20%)
Nov 5, 2025, 1:44 PM BST
GSK plc Revenue
GSK plc had revenue of 8.55B GBP in the quarter ending September 30, 2025, with 6.68% growth. This brings the company's revenue in the last twelve months to 32.17B, up 2.73% year-over-year. In the year 2024, GSK plc had annual revenue of 31.38B with 3.46% growth.
Revenue (ttm)
32.17B
Revenue Growth
+2.73%
P/S Ratio
2.24
Revenue / Employee
468.69K
Employees
68,629
Market Cap
71.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 31.38B | 1.05B | 3.46% |
| Dec 31, 2023 | 30.33B | 1.00B | 3.42% |
| Dec 31, 2022 | 29.32B | 4.63B | 18.74% |
| Dec 31, 2021 | 24.70B | 342.00M | 1.40% |
| Dec 31, 2020 | 24.35B | -9.40B | -27.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
| HUTCHMED (China) | 439.54M |
GSK plc News
- 12 hours ago - GSK PLC (GSK) Q3 2025 Earnings Call Highlights: Strong Sales Growth and Upgraded Guidance - GuruFocus
- 14 hours ago - Q3 2025 GSK plc Earnings Call Transcript - GuruFocus
- 1 day ago - We need clarity on big pharma’s tax breaks | Letters - The Guardian
- 2 days ago - Top global stories this week: GSK, Samsung and HSBC among notable names - Seeking Alpha
- 6 days ago - GSK Shares Surge 4.9% on Strong Q3 Earnings and Raised 2025 Outlook - GuruFocus
- 6 days ago - GSK plc (GSK) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - GSK (GSK) Surges on Strong Q3 Results and Improved Outlook - GuruFocus
- 6 days ago - GSK boss: Britain must reform drug pricing to become a life sciences superpower - The Guardian